医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

HOYA Group Appoints Gerald W. Bottero Global President of PENTAX Medical

2016年02月01日 PM08:30
このエントリーをはてなブックマークに追加


 

TOKYO

PENTAX Medical, a division of HOYA Group, has announced the appointment of Gerald W. Bottero to the position of Global President of PENTAX Medical as of February 1st, 2016.

“HOYA Group is pleased to have Gerald W. Bottero lead the global division of PENTAX Medical,” said Hiroshi Suzuki, President and CEO of HOYA Group. “Mr. Bottero brings a wealth of knowledge, insight and experience from his various global executive roles within HOYA, especially from our Life Care divisions. He has a proven track record of delivering results through developing and implementing strategic and operational changes in a global multicultural environment. We expect his leadership to further advance the PENTAX Medical growth strategy”.

Mr. Bottero joined HOYA Corporation in 1988 and has served HOYA in a number of Information Technology and Life Care segments. Most recently, he was the president of HOYA Vision Care from April 2005 through September 2014. Before that he served as president of HOYA Conbio, a medical laser firm focused on dermatology and hard tissue dentistry, and has also served as HOYA’s representative on the Boards of Directors of Decibel Instruments (intra-canal hearing aids) and Lifespex, Inc. (early detection of cervical cancer).

“I am truly honored to support the richly talented and highly dedicated global professionals of PENTAX Medical,” said Mr. Bottero. “Our mission is to ‘lead the leading edge’ in intelligent, software-rich endoscopic solutions for the early detection and treatment of cancer. Patients comprise the center of our universe; every day in every way, our job is to help doctors, nurses and biomeds improve the quality of patients’ lives. We are very excited about our opportunities, and by the enthusiastic feedback we have received from customers regarding new technologies we are developing for interactive imaging, single-use devices, mobility and scalable platforms.”

About PENTAX Medical

PENTAX Medical is a division of HOYA Group. Its mission is to improve the standard of patient care and quality of healthcare delivery by providing the best endoscopic products and services with a focus on QUALITY, CLINICALLY RELEVANT INNOVATION, and SIMPLICITY. Through leading edge R&D and manufacturing, PENTAX Medical provides endoscopic imaging devices and solutions to the global medical community. Headquartered in Japan, PENTAX Medical has a worldwide focus and presence with R&D, regional sales, service, and in-country facilities around the globe. PENTAX Medical employees represent the diverse countries where we do business, allowing us to provide innovative solutions tailored to meet local needs.
www.PENTAXmedical.com

View source version on businesswire.com: http://www.businesswire.com/news/home/20160201005528/en/

CONTACT

HOYA Group
PENTAX Medical
Kaori Kawashima
Mobile phone:
+81-80-4794-5842
GM, Global Marketing Communication
kaori.kawashima@pentaxmedical.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Quidel Receives PMDA Approval for Its Point-of-Care Sofia® Influenza A+B Assay
  • ドンペが中等度および重度の成人神経栄養性角膜炎患者の治療薬としてのOxervate®(Cenegermin点眼薬)に対するCHMPの肯定的意見を欧州で受領
  • Takeda Showcases Broadened Oncology Portfolio Through Data Presentations at Upcoming Medical Meetings
  • GORE® EXCLUDER® Iliac Branch Endoprosthesis Approved in Japan
  • LMD的V-Sensor传感器组将在印度用于测量生命体征